Clinical Trials List
2024-12-01 - 2027-12-31
Phase II
Recruiting10
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Trial Applicant
STATPLUS, INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/06/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 柯皓文 無
- 黃振洋 無
- 吳教恩 無
- Ping-Chih Hsu 無
- Cheng-Ta Yang 無
- 枋岳甫 無
- Chih-Hsi Kuo 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- JIN-YUAN SHIH
- 陳冠宇 無
- 廖斌志 無
- YEN-TING LIN
- 張允中 無
- 楊景堯 無
- Jih-Hsiang Lee
- James Chih-Hsin Yang 無
- 蔡子修 無
- Chong-Jen Yu
- Chia-Chi Lin
- 許嘉林 無
- 廖唯昱 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ying-Ming Tsai Tsai 無
- 李岱晃
- 莊政皓 無
- 李玫萱 無
- Chih-Jen Yang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
38 participants
-
Global
238 participants
